Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) Overview and Market Update

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) is a biopharmaceutical company focused on developing and commercializing innovative medicines to address unmet medical needs in central nervous system disorders. The company is known for its work on treatments for conditions like Parkinson's disease psychosis and Rett syndrome. Acadia faces competition from other pharmaceutical companies in the CNS space, such as Biogen and Eli Lilly.On March 2, 2026, Bank of America Securities adjusted its rating for Acadia Pharmac ...